Brice Foose - Net Worth and Insider Trading

Brice Foose Net Worth

The estimated net worth of Brice Foose is at least $0 dollars as of 2024-05-12. Brice Foose is the 10% Owner of InVivo Therapeutics Holdings Corp and owns about 0 shares of InVivo Therapeutics Holdings Corp (NVIVQ) stock worth over $0. Details can be seen in Brice Foose's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brice Foose has not made any transactions after 2023-02-06 and currently still holds the listed stock(s).

Transaction Summary of Brice Foose

To

Brice Foose Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brice Foose owns 1 companies in total, including InVivo Therapeutics Holdings Corp (NVIVQ) .

Click here to see the complete history of Brice Foose’s form 4 insider trades.

Insider Ownership Summary of Brice Foose

Ticker Comapny Transaction Date Type of Owner
NVIVQ InVivo Therapeutics Holdings Corp 2023-04-20 10 percent owner

Brice Foose Latest Holdings Summary

Brice Foose currently owns a total of 1 stock. Brice Foose owns 0 shares of InVivo Therapeutics Holdings Corp (NVIVQ) as of February 6, 2023, with a value of $0.

Latest Holdings of Brice Foose

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NVIVQ InVivo Therapeutics Holdings Corp 2023-02-06 0 0.40 0

Holding Weightings of Brice Foose


Brice Foose Form 4 Trading Tracker

According to the SEC Form 4 filings, Brice Foose has made a total of 1 transactions in InVivo Therapeutics Holdings Corp (NVIVQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in InVivo Therapeutics Holdings Corp is the sale of 330,000 shares on February 6, 2023, which brought Brice Foose around $122,100.

Insider Trading History of Brice Foose

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brice Foose Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brice Foose Ownership Network

Ownership Network List of Brice Foose

No Data

Ownership Network Relation of Brice Foose


Brice Foose Owned Company Details

What does InVivo Therapeutics Holdings Corp do?

Who are the key executives at InVivo Therapeutics Holdings Corp?

Brice Foose is the 10 percent owner of InVivo Therapeutics Holdings Corp. Other key executives at InVivo Therapeutics Holdings Corp include Chief Financial Officer Richard Christopher , director & CEO and CMO Richard M. Toselli , and Chief Legal Officer and GC Heather Hamel .

InVivo Therapeutics Holdings Corp (NVIVQ) Insider Trades Summary

Over the past 18 months, Brice Foose made 1 insider transaction in InVivo Therapeutics Holdings Corp (NVIVQ) with a net sale of 330,000.

In summary, during the past 3 months, insiders sold 0 shares of InVivo Therapeutics Holdings Corp (NVIVQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 330,000 shares of InVivo Therapeutics Holdings Corp (NVIVQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 330,000 shares.

InVivo Therapeutics Holdings Corp (NVIVQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

InVivo Therapeutics Holdings Corp Insider Transactions

No Available Data

Brice Foose Mailing Address

Above is the net worth, insider trading, and ownership report for Brice Foose. You might contact Brice Foose via mailing address: 236 Silent Meadow Drive, Lake St. Louis Mo 63367.

Discussions on Brice Foose

No discussions yet.